Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad.[2][3][4][5] The company manufactures and custom synthesizes generic APIs, intermediates.[6][7] The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals.[8] Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.[9]
History
The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry.[10] Following this, the company established its first Manufacturing facility in 1995 at Choutuppal, Telangana. In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam.
The company went public with its initial public offering (IPO) on 17 February 2003.[11][10] In 2010, the company established a research centre in Hyderabad.
Facilities
The company has three manufacturing facilities and three R&D centres across India:[12]
Manufacturing
- Choutuppal Unit - Lingojigudem village, Choutuppal mandal, Yadadri Bhuvanagiri district, Telangana
- DC SEZ Unit - Lingojigudem village, Choutuppal mandal, Yadadri Bhuvanagiri district, Telangana
- Export Oriented Unit - Chippada village, Bheemunipatnam mandal, Visakhapatnam district, Andhra Pradesh
- Divi's Pharma SEZ Unit - Chippada village, Bheemunipatnam mandal, Visakhapatnam district, Andhra Pradesh
- DSN SEZ Unit - Chippada village, Bheemunipatnam mandal, Visakhapatnam district, Andhra Pradesh
- DCV SEZ Unit - Chippada village, Bheemunipatnam mandal, Visakhapatnam district, Andhra Pradesh
References
- Statement of Audited Financial Results, Standalone and Consolidated, for the quarter and year ended March 31, 2025 Divi's Laboratories Limited, retrieved 28 May 2025^
- Company Profile-DIVIS LAB Dynamic Levels, retrieved 2020-09-15^
- Company Profile for Divi's Laboratories Ltd Reuters, retrieved 2020-09-15^
- Divi's Laboratories Ltd Company profile Bloomberg L.P., retrieved 2020-09-15^
- DIVI'S LABORATORIES LIMITED - Company, directors and contact details www.zaubacorp.com, retrieved 2020-09-15^
- Top API Manufacturing Company In Hyderabad, India & World Divis Laboratories World’s largest API manufacturing facility, retrieved 2020-09-15^
- Dun Bradstreet. Divi's Laboratories company profile dnb.com^
- Divis Nutraceuticals. Press Release: Divi's Nutraceuticals launches CaroNat for natural food and beverage coloration Divi's Nutraceuticals, 2021-09-14, retrieved 2022-07-27^
- Top Pharmaceuticals & Drugs Stocks in India by Market Capitalisation www.moneycontrol.com, retrieved 15 February 2023^
- Divis Laboratories > Company History > Pharmaceuticals > Company History of Divis Laboratories - BSE: 532488, NSE: DIVISLAB moneycontrol.com, retrieved 2020-09-17^
- Divis Labs Fixes Rs 130 Per Share As Floor Price For IPO The Financial Express, 2003-02-11, retrieved 2020-09-18^
- Divi's Laboratories. Annual Report divislabs.com^